247 related articles for article (PubMed ID: 29743369)
1. Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
Elsayed H; Nabi G; McKinstry WJ; Khoo KK; Mak J; Salazar AM; Tenbusch M; Temchura V; Überla K
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743369
[TBL] [Abstract][Full Text] [Related]
2. Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines.
Temchura V; Überla K
Curr Opin HIV AIDS; 2017 May; 12(3):272-277. PubMed ID: 28422791
[TBL] [Abstract][Full Text] [Related]
3. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
4. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504
[TBL] [Abstract][Full Text] [Related]
5. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells.
Storcksdieck genannt Bonsmann M; Niezold T; Temchura V; Pissani F; Ehrhardt K; Brown EP; Osei-Owusu NY; Hannaman D; Hengel H; Ackerman ME; Streeck H; Nabi G; Tenbusch M; Überla K
J Immunol; 2015 Nov; 195(10):4861-72. PubMed ID: 26466954
[TBL] [Abstract][Full Text] [Related]
7. Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help.
Damm D; Rojas-Sánchez L; Theobald H; Sokolova V; Wyatt RT; Überla K; Epple M; Temchura V
Nanomaterials (Basel); 2019 Sep; 9(10):. PubMed ID: 31569763
[TBL] [Abstract][Full Text] [Related]
8. GagPol-specific CD4⁺ T-cells increase the antibody response to Env by intrastructural help.
Nabi G; Genannt Bonsmann MS; Tenbusch M; Gardt O; Barouch DH; Temchura V; Uberla K
Retrovirology; 2013 Oct; 10():117. PubMed ID: 24156704
[TBL] [Abstract][Full Text] [Related]
9. Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
Joachim A; Bauer A; Joseph S; Geldmacher C; Munseri PJ; Aboud S; Missanga M; Mann P; Wahren B; Ferrari G; Polonis VR; Robb ML; Weber J; Tatoud R; Maboko L; Hoelscher M; Lyamuya EF; Biberfeld G; Sandström E; Kroidl A; Bakari M; Nilsson C; McCormack S
PLoS One; 2016; 11(5):e0155702. PubMed ID: 27192151
[TBL] [Abstract][Full Text] [Related]
10. Methanobrevibacter smithii archaeosomes-entrapped mzNL4-3 virus-like particles induce specific T helper 1-oriented cellular and humoral responses against HIV-1.
Salmani AS; Aghasadeghi MR; Nategh R; Mokhtari-Azad T; Siadat SD
Curr HIV Res; 2013 Sep; 11(6):491-7. PubMed ID: 24329177
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
Poteet E; Lewis P; Chen C; Ho SO; Do T; Chiang S; Labranche C; Montefiori D; Fujii G; Yao Q
Vaccine; 2016 Nov; 34(48):5886-5894. PubMed ID: 27997339
[TBL] [Abstract][Full Text] [Related]
12. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
[TBL] [Abstract][Full Text] [Related]
13. Modulation of immune responses to liposomal vaccines by intrastructural help.
Damm D; Suleiman E; Wagner JT; Klessing S; Pfister F; Elsayed H; Walkenfort B; Stobrawe J; Mayer J; Lehner E; Müller-Schmucker SM; Hasenberg M; Wyatt RT; Vorauer-Uhl K; Temchura V; Überla K
Eur J Pharm Biopharm; 2023 Nov; 192():112-125. PubMed ID: 37797679
[TBL] [Abstract][Full Text] [Related]
14. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers.
Carnathan DG; Kaushik K; Ellebedy AH; Enemuo CA; Gebru EH; Dhadvai P; Rasheed MAU; Pauthner MG; Ozorowski G; Ahmed R; Burton DR; Ward AB; Silvestri G; Crotty S; Locci M
Front Immunol; 2020; 11():1213. PubMed ID: 32612608
[TBL] [Abstract][Full Text] [Related]
16. Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.
Vzorov AN; Wang L; Chen J; Wang BZ; Compans RW
Virology; 2016 Feb; 489():141-50. PubMed ID: 26761396
[TBL] [Abstract][Full Text] [Related]
17. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
18. Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.
Rosengarten JF; Schatz S; Wolf T; Barbe S; Stitz J
Virology; 2022 Mar; 568():41-48. PubMed ID: 35101772
[TBL] [Abstract][Full Text] [Related]
19. Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
Bridge SH; Sharpe SA; Dennis MJ; Dowall SD; Getty B; Anson DS; Skinner MA; Stewart JP; Blanchard TJ
Virol J; 2011 Sep; 8():429. PubMed ID: 21899739
[TBL] [Abstract][Full Text] [Related]
20. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
